Watts Water Technologies, Inc. (WTS) Earnings
Watts Water Technologies, Inc. is expected to report next earnings on August 5, 2026 (in NaN days), with a consensus EPS estimate of $3.33. WTS has beaten EPS estimates in 12 of its last 12 reported quarters (average surprise +12.2% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 7, 2026 | $2.72 | $3.04 | +11.8% | $677M | +6.1% |
| Feb 11, 2026 | $2.36 | $2.62 | +11.0% | $625M | +1.9% |
| Nov 5, 2025 | $2.26 | $2.50 | +10.6% | $612M | +6.1% |
| Aug 6, 2025 | $2.68 | $3.09 | +15.3% | $644M | +14.6% |
| Oct 30, 2024 | $1.99 | $2.03 | +2.0% | $544M | +0.6% |
| Nov 1, 2023 | $1.83 | $2.04 | +11.5% | $504M | +1.4% |
| Aug 2, 2023 | $2.04 | $2.34 | +14.7% | $533M | +8.3% |
| May 3, 2023 | $1.64 | $1.92 | +17.1% | $472M | -0.3% |
| Feb 8, 2023 | $1.53 | $1.60 | +4.6% | $502M | +3.2% |
| Nov 2, 2022 | $1.55 | $1.79 | +15.5% | $488M | +2.0% |
| Aug 3, 2022 | $1.63 | $2.11 | +29.4% | $527M | +7.4% |
| May 3, 2022 | $1.37 | $1.63 | +19.0% | $463M | +4.6% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q1 FY2026 · May 7, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
- Strong start to the year with record first quarter sales and earnings. - Portfolio spans diverse end markets, reallocating resources to strong demand areas like institutional and data centers. - Approximately 60% of sales driven by repair and replacement activity. - Maintaining full year outlook despite macro and geopolitical uncertainty. - Balance sheet strong, providing flexibility for capital allocation. - Reaffirming full year 2026 outlook presented in February, assuming short-term Middle East conflict, current tariff structure in place, no IEPA tariff refunds. - Second quarter estimates incorporate negative impact from product rationalization under 80-20 initiative, incremental sales from acquisitions, and foreign exchange benefit. - Data center sales expected to offset direct impact of Middle East conflict in second quarter.
Guidance
- Reaffirming full year 2026 outlook presented in February, maintaining consolidated and regional sales outlooks. Consolidated organic sales growth between +2% and +6%, reported sales growth between +8% and +12%. Maintaining full year adjusted EBITDA and adjusted operating margin outlook. - Second quarter reported sales expected to increase 10-14%, organic sales up 4-8%. Americas mid to high single-digit growth (tough compare to last year's pull-forward sales), Europe low single-digit decline, apnea low to mid-single-digit growth. EBITDA margin expected 22.3-22.9%, operating margin 20-20.6%. Price and volume leverage in Americas and apnea offset by acquisition dilution of ~70 basis points. - Anticipate foreign exchange benefit of approx $5 million. Incremental sales from acquisitions projected at 25-30 million for Americas and ~5 million for apnea.
Segment performance
Americas segment margin increased 80 basis points to 24.2%, apnea segment margin increased 120 basis points to 18.7%, while Europe segment margin decreased 20 basis points to 13.7%. Adjusted earnings per share was $3.04, a 28% year-over-year increase. Free cash flow for the quarter was $7 million. Consolidated organic sales growth expected to be between +2% and +6% for full year 2026, reported sales growth between +8% and +12%. Second quarter reported sales expected to increase 10-14%, organic sales up 4-8%. Americas mid to high single-digit growth, Europe low single-digit decline, apnea low to mid-single-digit growth. Second quarter EBITDA margin expected 22.3-22.9%, operating margin 20-20.6%.
Risks & headwinds
- Macro and geopolitical uncertainty. - Middle East conflict impact on sales and margins, with expected data center sales offsetting some direct impact but still a factor. - Product rationalization under 80-20 initiative negatively impacting sales in Europe and Americas. - Inflation and related costs affecting pricing and margins, with need to monitor and potentially implement additional price increases. - Uncertainty regarding the duration and broader impact of the Middle East conflict on various regions and business segments.
Analyst Q&A
Q: Dumb question about full year guidance, any reason second half might be weaker?
A: Being prudent, depends on how long war goes on, if over quickly there are opportunities in second half, will reassess in three months.
Q: Details on data centers, addressable market, growth?
A: Over a billion dollar addressable market, goal is high double digit growth in data center for the year, teams innovating, accretive to margins.
Q: Margin cadence, price costs?
A: Staying in front of price cost, international units put in additional price increases, evaluating U.S. for possible additional increases, second half volume assumptions flatish with opportunities if outlook increases.
Q: 80-20 initiative progress, sales drag, benefits?
A: Expect ramp up in back half of year, ~$15 million in first half, will significantly increase in back half, started with price increases.
Q: Price mix vs volume in North America, need for incremental pricing?
A: Watching costs closely, international units impacted more, price cost ~8% in first quarter, preparing for additional price increases if needed.
Q: Order book, inventory investment?
A: Order book in line with Q2 forecast, inventory strategic investment for data center lead times, net net expected to work through by end of year.
Q: Impact of Middle East conflict on sales and margins, first quarter vs second?
A: $8 million sales impact in Middle East, margin headwind from price decline, pull forward last year, Middle East conflict margin headwind.
Q: Europe margin, why not strong expansion?
A: Seasonality, volume down, 80-20 piece, small mix issue, relatively stabilized now.
Q: Resi market demand trends?
A: Resi a little softer than anticipated due to uncertainty and fuel costs, repair and replacement holding up, remodeling softer, new construction soft.
Q: Institutional market growth areas, Nexa uptake?
A: Schools and hospitals in institutional market, Nexa continues to grow, being put on all products to protect core business and command higher pricing.
Q: M&A environment?
A: Strong pipeline, disciplined, will continue to cultivate, watch for strategic and financial sense acquisitions.